Advertisement GenoMed diabetes program engaged by Michigan Indian tribe - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

GenoMed diabetes program engaged by Michigan Indian tribe

Shares in GenoMed, a Missouri-based firm that uses genomics to prevent disease, have risen almost five percent after it announced an agreement with the Burt Lake Band of the Ottawa and Chippewa Indians of Michigan to help manage diabetes within the Burt Lake tribal community.

Like all two million North American Indians, the Burt Lake Band has an extremely high rate of adult-onset diabetes. At a recent Tribal Council meeting, GenoMed was approved to enrol tribal members into the company’s clinical outcomes improvement program (COIP) at their request. The Burt Lake Band is the first Indian tribe to engage GenoMed.

Payment of $67 per member per month is being deferred until after the Band achieves federal recognition, which is expected within the coming year.

“Diabetes is the number one health problem in our tribe,” commented Curtis Chambers, chairman of the board of the Burt Lake Band. “We are happy to use cutting edge medicine against this scourge of our people and are appreciative of GenoMed’s willingness to work with our members.”

“We greatly appreciate the opportunity that Chief Chambers has given us to help his tribe,” said Dr David Moskowitz, GenoMed’s CEO and chief medical officer. “I’m confident that we’ll be able to show improved patient outcomes within a year.”